Schindler Christoph, Dobrev Dobromir, Grossmann Matthias, Francke Klaus, Pittrow David, Kirch Wilhelm
Institute of Clinical Pharmacology, Medical Faculty, Dresden University of Technology, Germany.
Clin Pharmacol Ther. 2004 Jan;75(1):49-59. doi: 10.1016/j.clpt.2003.09.009.
Recent studies suggest that stimulation of beta-adrenergic receptors results in both endothelium-dependent and endothelium-independent venodilation, but results of former studies are inconsistent. This study was designed to elucidate the underlying mechanisms of isoproterenol (INN, isoprenaline)-induced venodilation by investigation of dorsal hand vein responses.
In phenylephrine-constricted veins, isoproterenol (2-514 ng/min) was infused with and without oral pretreatment with 1 g acetylsalicylic acid (n = 7) or 5 mg of the selective beta(1)-adrenergic receptor antagonist bisoprolol (n = 7). In addition, isoproterenol was coinfused with the nitric oxide inhibitor N(G)-monomethyl-l-arginine (l-NMMA) (6.3 micromol/min [n = 6]), with selective blockers of calcium (Ca(++))-dependent potassium (K(+)) channels (tetraethylammonium, 300 microg/min [n = 6]) and adenosine triphosphate (ATP)-sensitive K(+) channels (glyburide [INN, glibenclamide], 20 microg/min [n = 6]) or with the cyclic guanosine monophosphate inhibitor methylene blue (13 microg/min [n = 6]). Finally, L-NMMA was coinfused with potassium chloride (20 mmol/L) to inhibit hyperpolarization (n = 6).
Isoproterenol induced dose-dependent venodilation to 67.4% +/- 6.8%. Oral pretreatment with bisoprolol (P =.340) or acetylsalicylic acid (P =.760) did not affect isoproterenol-induced venodilation. Coinfusion of isoproterenol and L-NMMA relaxed the veins to the same extent as in the presence of isoproterenol alone. Neither inhibition of ATP-sensitive K(+) channels (P =.196) nor blockade of Ca(++)-dependent K(+) channels (P =.640) modulated isoproterenol-induced venodilation. In contrast, methylene blue reduced the maximum response to isoproterenol by about one third (68.5% +/- 4.3% versus 41.7% +/- 5.5%, P =.001). Infusion of L-NMMA alone raised vein size to 38.8% +/- 6.5%, yielding an L-NMMA-sensitive increase of 20% (P =.001), which was antagonized by coinfusion of potassium chloride to 17.1% +/- 6.7% (P =.02).
Isoproterenol dilates human hand veins exclusively via beta(2)-adrenergic receptors without involvement of endothelium-derived epoprostenol. Although a contribution of endothelium-derived nitric oxide appears unlikely, the venodilating effect of L-NMMA could have obscured the nitric oxide component of isoproterenol. beta(2)-Adrenergic receptor-mediated dilation is mediated in part by cyclic guanosine monophosphate-dependent mechanisms, whereas ATP- and Ca(++)-dependent K(+) channels are not involved, excluding a significant contribution of smooth muscle cell hyperpolarization. In addition, high concentrations of the nitric oxide synthase blocker L-NMMA dilate human hand veins via activation of endothelium-derived hyperpolarizing factors.
近期研究表明,刺激β-肾上腺素能受体可导致内皮依赖性和非内皮依赖性静脉扩张,但既往研究结果并不一致。本研究旨在通过观察手背静脉反应来阐明异丙肾上腺素诱导静脉扩张的潜在机制。
在去氧肾上腺素收缩的静脉中,分别在口服1 g阿司匹林(n = 7)或5 mg选择性β₁-肾上腺素能受体拮抗剂比索洛尔(n = 7)预处理前后,输注异丙肾上腺素(2 - 514 ng/min)。此外,将异丙肾上腺素与一氧化氮抑制剂N⁰-单甲基-L-精氨酸(L-NMMA)(6.3 μmol/min [n = 6])、钙(Ca²⁺)依赖性钾(K⁺)通道选择性阻滞剂(四乙铵,300 μg/min [n = 6])、三磷酸腺苷(ATP)敏感性K⁺通道阻滞剂(格列本脲[INN,优降糖],20 μg/min [n = 6])或环鸟苷单磷酸抑制剂亚甲蓝(13 μg/min [n = 6])联合输注。最后,将L-NMMA与氯化钾(20 mmol/L)联合输注以抑制超极化(n = 6)。
异丙肾上腺素诱导剂量依赖性静脉扩张至67.4%±6.8%。比索洛尔(P = 0.340)或阿司匹林(P = 0.760)口服预处理不影响异丙肾上腺素诱导的静脉扩张。异丙肾上腺素与L-NMMA联合输注使静脉扩张程度与单独使用异丙肾上腺素时相同。抑制ATP敏感性K⁺通道(P = 0.196)和阻断Ca²⁺依赖性K⁺通道(P = 0.640)均未调节异丙肾上腺素诱导的静脉扩张。相反,亚甲蓝使对异丙肾上腺素的最大反应降低约三分之一(68.5%±4.3%对41.7%±5.5%,P = 0.001)。单独输注L-NMMA使静脉大小增加至38.8%±6.5%,L-NMMA敏感性增加20%(P = 0.001),氯化钾联合输注可将其拮抗至17.1%±6.7%(P = 0.02)。
异丙肾上腺素仅通过β₂-肾上腺素能受体扩张人手部静脉,不涉及内皮衍生的依前列醇。虽然内皮衍生的一氧化氮似乎不太可能起作用,但L-NMMA的静脉扩张作用可能掩盖了异丙肾上腺素的一氧化氮成分。β₂-肾上腺素能受体介导的扩张部分由环鸟苷单磷酸依赖性机制介导,而ATP和Ca²⁺依赖性K⁺通道不参与,排除了平滑肌细胞超极化的显著作用。此外,高浓度的一氧化氮合酶阻滞剂L-NMMA通过激活内皮衍生的超极化因子扩张人手部静脉。